CJC-1295 (With DAC) is a high-purity research-only peptide studied for its extended activity in growth hormone–related signaling pathways. The inclusion of the Drug Affinity Complex (DAC) allows for prolonged receptor interaction, making this compound suitable for laboratory research focused on sustained endocrine signaling and peptide-receptor dynamics.

CJC-1295 (With DAC) is designed for researchers investigating long-acting growth hormone–releasing hormone (GHRH) analogs and their influence on downstream metabolic and cellular signaling pathways in controlled research environments.

Key Research Characteristics

CJC-1295 (With DAC) – A modified GHRH analog with drug affinity complex technology, studied for prolonged growth hormone signaling and extended receptor binding.

Research Focus Areas

• Sustained growth hormone signaling pathways

• Endocrine and metabolic research

• Long-acting peptide-receptor interaction studies

• Growth hormone release mechanism analysis

Quality & Specifications

• High-purity CJC-1295 with DAC (≥99%)

• Lyophilized for laboratory stability

• Independently tested for identity and purity

• Manufactured in controlled research-grade facilities

Important Notice

For Research Use Only.

This product is not intended for human or animal consumption, clinical use, or diagnostic purposes. Intended exclusively for qualified researchers conducting laboratory research.